医学
心脏病学
冠状动脉疾病
内科学
心绞痛
缺血
冠状动脉
心肌缺血
人口
冠状动脉粥样硬化
临床试验
动脉
心肌梗塞
环境卫生
作者
Alexander Polyak,Janet Wei,Martha Gulati,Noel Bairey Merz
标识
DOI:10.1016/j.ahjo.2023.100352
摘要
Ischemia with no obstructive coronary arteries (INOCA) is defined as patients with evidence of myocardial ischemia without obstructive coronary artery disease. About 3-4 million people in the United States have INOCA, more commonly affecting women, and carries adverse morbidity, mortality, and relatively high healthcare costs. The pathophysiology of INOCA appears to be multi-factorial with a variety of contributing mechanisms. Diagnosis of INOCA is suggested by non-invasive or invasive testing consistent with myocardial ischemia. Due to the high prevalence of coronary risk factors and atherosclerosis in the INOCA population, current treatment strategies target angina, coronary atherosclerosis, and atherosclerotic risk factors, as well as burgeoning treatment of coronary microvascular dysfunction (CMD). Ongoing clinical trials are assessing different options.
科研通智能强力驱动
Strongly Powered by AbleSci AI